Multiple myeloma lifestyle study

Not Applicable

Completed

• Conditions: Topic: Cancer; Subtopic: Haematological Oncology; Disease: Myeloma; Cancer

• Registration Number: ISRCTN38480455
• Lead Sponsor: niversity College London

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32435057/ (added 22/05/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-29
• Study Completion: 2017-12-31
• Last Update Posted: 1 June 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 131

Inclusion Criteria

1. Myeloma survivors, who are assigned to UCLH myeloma clinics
2. Stable disease for at least 6 weeks, off treatment or on maintenance or consolidation treatment
3. Ability to give informed consent
4. A good performance status (ECOG 02)
5. Clinically able to carry out an exercise training programme on a regular basis (assessed by initial screening)
6. Aged at least 18

Exclusion Criteria

1. Spinal instability (as assessed on radiology in multidisciplinary team (MDT)) meetings
2. Those who have recently (within 4 weeks) had spinal or other surgery for pathological fractures
3. An abnormal resting ECG, where clinically indicated unexplained by further cardiological workup
4. At risk of pathological fracture (Mirel’s score, see Appendix 1 of Protocol)
5. Already participating in an exercise programme as part of a research study
6. Unstable angina
7. Musculoskeletal disease limiting mobility
8. Cognitive impairment that impedes ability to complete questionnaires

Study & Design

• Study Type: Interventional
• Study Design: Not specified